(32 days)
No
The device description and performance studies focus on mechanical safety features and standard medical device testing, with no mention of AI or ML.
No.
This device is for the aspiration/injection of fluids and includes a safety mechanism for preventing needlesticks. It does not provide any therapeutic action itself.
No.
The device is a safety needle intended for aspiration and injection of fluids, not for diagnosing medical conditions.
No
The device description clearly outlines a physical hypodermic needle with a hinged safety sheath and locking mechanisms, indicating it is a hardware device. There is no mention of software components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "aspiration and injection of fluids for medical purposes." This describes a procedure performed on a patient, not a test performed on a sample from a patient to diagnose a condition.
- Device Description: The description focuses on the physical components and safety features of a hypodermic needle and syringe. It does not mention any reagents, test strips, or other components typically associated with in vitro diagnostic testing.
- Lack of IVD-related terms: There is no mention of analyzing samples, detecting analytes, or providing diagnostic information.
IVD devices are used to examine specimens derived from the human body (like blood, urine, or tissue) to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. This device is used for administering or withdrawing substances directly from the body.
N/A
Intended Use / Indications for Use
The Terumo SurGuard®3 Safety Hypodermic Needle device is intended for use in the aspiration and injection of fluids for medical purposes. The Terumo SurGuard 3 Safety Needle is compatible for use with standard luer slip and luer lock syringes.
Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needlestick.
Product codes (comma separated list FDA assigned to the subject device)
80FMI, 80MEG
Device Description
The Terumo SurGuard 3 Safety Hypodermic Needle consists of a hypodermic needle with a hinged safety sheath attached to the connector hub with or without an attached hypodermic syringe. This device features a hinged safety sheath attached to the needle hub. The safety sheath contains two locking mechanisms, the tooth-cannula and sheath-collar which are simultaneously activated when manually pressed over the needle immediately after use and just prior to disposal to minimize the possibility of sharps injury. The safety sheath is activated with a one-handed operation by pressing the sheath either by finger, thumb or surface activation.
The safety sheath has a finger guide area consisting of a circular dent (for thumb activation) and ramp (for finger activation) which gives the user a concrete confirmation that the user's finger is in the appropriate position in performing the activation. The ramp has steps to provide strong grasp when activating the sheath, There are two stoppers located at the end of the circular dent and ramp which prevent the user's finger from going towards the cannula during activation. Another method of activation is by manually pressing the safety sheath over the needle using a firm surface.
The locking mechanisms are positioned within the center and proximal end of the sheath. The hinge feature allows the medical practitioner to flexibly adjust the sheath to its desired position for use.
The Terumo SurGuard 3 Safety Hypodermic Needle will be individually packaged and sterilized by electron beam as a safety needle only or as a safety needle with attached Terumo syringe.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Testing:
- Tests performed: Sheath Activation, Sheath Deactivation, Sheath Removal, Sheath Radial, Sheath Retraction, Protector Fitting, Collar removal, Sheath Puncture, Adhesive Hold, Needle Penetration, Manual Sheath Activation (Finger Activation, Thumb Activation, Surface Activation), Measurement Testing, Manual Sheath Activation by analytical balance.
- Conclusion: Results of the verification testing performed on both the predicate device and the proposed device met the acceptance criteria of the functional performance tests of both devices.
Simulated Use Study:
- Objective: To confirm that the safety feature of the proposed device can be safely activated by following the Instructions For Use of the device.
- Methodology: The study was conducted in a simulated clinical environment and the safety feature activation was performed by healthcare workers with varied amounts of experience.
- Conclusion: It was concluded that the proposed Terumo SurGuard 3 Safety Hypodermic Needle met its intended use, and the Instructions for Use were adequate for safe and effective activation of the safety feature.
Shelf Life Testing:
- Methodology: Shelf life tests were performed on both the predicate device (K113422) and the proposed Terumo SurGuard 3 Safety Hypodermic Needle and with attached syringe (1cc/ml) using accelerated aged samples to simulate a 5-year (60 months) shelf life, in accordance with ASTM F-1980.
- Tests performed: Sheath Activation, Sheath Deactivation, Sheath Removal, Sheath Radial, Sheath Retraction, Protector Fitting, Collar removal, Sheath Puncture, Adhesive Hold, Needle Penetration, Manual Sheath Activation (Finger Activation, Thumb Activation, Surface Activation), Package Seal Strength.
- Conclusion: Results of verification testing indicated that the functional performance of the proposed Terumo SurGuard®3 Safety Hypodermic Needle and with attached syringe (1cc/ml) is acceptable throughout a 5-year (60months) shelf life. The shelf-life will be confirmed with real time testing.
Biocompatibility Testing:
- Methodology: Biocompatibility was established for the predicate device (K113422), which is comprised of blood contacting materials identical to the Terumo SurGuard®3 Safety Hypodermic Needle (26G, 27G and 30G) and with attached syringe (1cc/ml) device. No changes have been made since 510(k) clearance that would require re-testing. The device's blood contacting materials were tested in accordance with the tests recommended in the FDA General Program Memorandum #G95-1 (5/1/95): Use of International Standard ISO - 10993, "Biological Evaluation of Medical Devices part 1: Evaluation and Testing".
- Conclusion: Biocompatibility established under K113422 is still applicable. Results of the testing demonstrate that the blood contacting materials are biocompatible. None of the data raises any new issues of safety and effectiveness.
Product Risk Analysis:
- Conclusion: A product risk analysis was conducted and there were no new issues of safety and effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K113422 TERUMO® SurGuard® 3 Safety Hypodermic Needle with or without syringe
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5570 Hypodermic single lumen needle.
(a)
Identification. A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.(b)
Classification. Class II (performance standards).
0
K1224'9
page 1 of 10
AUG 2 8 2012
510(k) SUMMARY
| Manufacturer/Owner | : TERUMO (PHILIPPINES) CORPORATION
124 East Main Avenue, Laguna Technopark,
Biñan, Laguna, Philippines |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Prepared by | : Ma. Cristina Faderagao – Supervisor Regulatory Affairs
Tel. (+63) 49 541 2111
Fax (+63) 49 541 2121 : |
| Date prepared | : June 22, 2012 |
| Contact person | : Phillip Michael Lester
Regulatory Affairs Specialist
Terumo Medical Corporation
950 Elkton Boulevard
Elkton, MD 21921
Phone #: (410) 392-7321
Fax #: (410) 398-6079 |
E-mail: philmichael.lester@terumomedical.com
··
.
・ ・・
.
.
·
14
·
:
1
A. DEVICE NAME
Proprietary Name
TERUMO® SurGuard®3 Safety Hypodermic Needle TERUMO® SurGuard®3 Hypodermic Syringe with Safety Needle
Classification Name
Hypodermic Single Lumen Needle (880.5570) with antistick
Product Code: 80FMI / 80MEG
Classification: Class II
Common Name
Hypodermic Needle with Safety Sheath or Needle with needle protection device.
B. INTENDED USE
The Terumo SurGuard®3 Safety Hypodermic Needle device is intended for use in the aspiration and injection of fluids for medical purposes. The Terumo SurGuard 3 Safety Needle is compatible for use with standard luer slip and luer lock syringes.
Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needlestick.
Note: This is the same intended use as the predicate device, Terumo SurGuard®3 Safety Hypodermic Needle.
C. DEVICE DESCRIPTION
The Terumo SurGuard 3 Safety Hypodermic Needle consists of a hypodermic needle with a hinged safety sheath attached to the connector hub with or without an attached hypodermic syringe. This device features a hinged safety sheath attached to the needle hub. The safety sheath contains two locking mechanisms, the tooth-cannula and sheath-collar which are simultaneously activated when
2
K12249
manually pressed over the needle immediately after use and just prior to disposal to minimize the possibility of sharps injury. The safety sheath is activated with a one-handed operation by pressing the sheath either by finger, thumb or surface activation.
The safety sheath has a finger guide area consisting of a circular dent (for thumb activation) and ramp (for finger activation) which gives the user a concrete confirmation that the user's finger is in the appropriate position in performing the activation. The ramp has steps to provide strong grasp when activating the sheath, There are two stoppers located at the end of the circular dent and ramp which prevent the user's finger from going towards the cannula during activation. Another method of activation is by manually pressing the safety sheath over the needle using a firm surface.
The locking mechanisms are positioned within the center and proximal end of the sheath. The hinge feature allows the medical practitioner to flexibly adjust the sheath to its desired position for use.
The Terumo SurGuard 3 Safety Hypodermic Needle will be individually packaged and sterilized by electron beam as a safety needle only or as a safety needle with attached Terumo syringe.
D. SUBSTANTIAL EQUIVALENCE
The Terumo SurGuard®3 Safety Hypodermic Needle and with attached syringe submitted in this 510(k) and manufactured by Terumo (Philippines) Corporation is substantially equivalent to:
-
- K113422 TERUMO® SurGuard® 3 Safety Hypodermic Needle with or without syringe manufactured by Terumo (Philippines) Corporation.
E. SUMMARY OF TECHNOLOGICAL CHARACTERISTICS
Principle of Operation and Technology
The Terumo SurGuard 3 Safety Hypodermic Needle device with and without syringe manufactured by Terumo (Philippines) Corporation, subject of this 510(k), and the predicate devices covered under K113422 are operated manually.
ા ર
3
K122249
page 4 of 10
Materials
All materials for the Terumo SurGuard®3 Safety Hypodermic Needle and with attached syringe are the same as the materials of the SurGuard3 as submitted in the 510(k), K113422. The 1 cc/ml syringe plunger is made up of polystyrene, while the 3, 5, and 10 cc/ml syringes utilize polypropylene for the plunger; however, both polystyrene and polypropylene were cleared for use in the plunger under K113422.
Specifications
The new needle gauge sizes to be added under this 510(k) are 26G, 27G, 30G and the new needle lengths are 3/8", 5/8", and 1/2". The syringe size to be added is 1cc/ml, as K113422 only provided for 3, 5, and 10 cc/ml syringe and needle combinations. This submission also provides for new needle gauge and length combinations for 23G and 25G needles and 1" needle length which were cleared under K113422. Finally, this submission includes the shorter safety sheath with modified design for all new gauge and needle length combinations.
The proposed Terumo SurGuard®3 Safety Hypodermic Needle comes with a shorter safety sheath. The inside rib design of the sheath was modified, specifically extending rib 2 towards the inside wall of the sheath and modifying rib 3 to be symmetrical. This design allows the cannula to slide towards the center of the sheath during the activation.
For further clarification of the reason for this submission and differences from the previous 510(k), Tables 1 and 2 on the following page are included here. Table 1 shows the needle gauges x needle length combinations both new for this submission and those cleared under previous 510(k), K113422. Table 2 demonstrates gauge and needle length combinations and the syringe size specific to each needle gauge x needle length. "X" demonstrates clearance under previous 510(k), K113422, while items new for this submission are denoted by "New."
4
page
ਸਿੰ
. .
.
ా
്ര
Terumo (Philippines) Corporation
SurGiaard3 Safety Needle
Special 510k
Section II 510k
Section II 510(k) Summary
| TABLE 1 | Needle Length | ||||||
|---|---|---|---|---|---|---|---|
| 3/8" | יי2/1 | 5/8" | ] ** | 1 1/2" | 2" | ||
| (9mm) | (13mm) | (16mm) | (25mm) | (38mm) | (51mm) | ||
| 18G | X | X | |||||
| 19G | X | X | |||||
| 20G | X | X | X | ||||
| 21G | X | X | |||||
| Gauge | 22G | X | X | ||||
| Size | 23G | New | X | ||||
| 25G | New | New | X | ||||
| 26G | New | New | |||||
| 27G | New | ||||||
| 30G | New |
Table 1 – Needle Gauges x Needle Length
Table 2 - Needle Length and Gauge x Syringe
| TABLE 2 | Syringe Size | |||||
|---|---|---|---|---|---|---|
| 1 cc/ml | 3 cc/ml | 5 cc/ml | 10 cc/ml | |||
| Needle Gauge x | ||||||
| Needle Length | 18G x 1" | |||||
| 18G x 1 ½" | ||||||
| 19G x 1" | ||||||
| 19G x 1 ½" | ||||||
| 20G x 1" | X | X | X | |||
| 20G x 1 ½" | X | X | X | |||
| 20G x 2" | ||||||
| 21G x 1" | X | X | ||||
| 21G x 1 ½" | X | X | ||||
| 22G x 1" | X | |||||
| 22G x 1 ½" | X | |||||
| 23G x 1" | New | |||||
| 23G x 1 ½" | ||||||
| 25G x 5/8" | New | New | ||||
| 25G x 1" | New | |||||
| 25G x 1 ½" | ||||||
| 26G x 3/8" | New |
.
5
| TABLE 2 | Syringe Size | ||||
|---|---|---|---|---|---|
| 1 cc/ml | 3 cc/ml | 5 cc/ml | 10 cc/ml | ||
| Needle Gauge x | |||||
| Needle Length | 26G x ½" | ||||
| 27G x ½" | New | ||||
| 30G x ½" |
1777499
ਹੰਦਿ
IO
The above cleared devices (indicated as "X") serve as predicate for the devices that are subject of this 510(k). '
| Product Code | Description |
|---|---|
| SG3-2325 | 23gauge x 1" (25mm) safety hypodermic needle |
| SG3-2516 | 25gauge x 5/8" (16mm) safety hypodermic |
| needle | |
| SG3-2525 | 25gauge x 1" (25mm) safety hypodermic needle |
| SG3-2609 | 26gauge x 3/8" (9mm) safety hypodermic needle |
| SG3-2613 | 26gauge x 1/2" (13mm) safety hypodermic |
| needle | |
| SG3-2713 | 27gauge x 1/2" (13mm) safety hypodermic |
| needle | |
| SG3-3013 | 30 gauge x 1/2" (13mm) safety hypodermic |
| needle | |
| SG3-01T2516 | 25gauge x 5/8" (16mm) safety hypodermic |
| needle, with 1cc/ml syringe | |
| SG3-01T2609 | 26gauge x 3/8" (9mm) safety hypodermic needle, |
| with 1cc/ml syringe | |
| SG3-01T2713 | 27gauge x 1/2" (13mm) safety hypodermic |
| needle, with 1cc/ml syringe | |
| SG3-03L2325 | 23gauge x 1" (25mm) safety hypodermic needle, |
| with 3cc/ml syringe | |
| SG3-03L2516 | 25gauge x 5/8" (16mm) safety hypodermic |
| needle with 3cc/ml syringe | |
| SG3-03L2525 | 25gauge x 1" (25mm) safety hypodermic needle |
| with 3cc/ml syringe |
Specifications for product proposed in this 510(k)
6
Performance
The following tests were performed on the Terumo SurGuard®3 Safety Hypodermic Needle and with attached syringe.
Performance Testing
These tests were performed on both predicate device K113422 and the proposed device:
- . Sheath Activation
- Sheath Deactivation .
- Sheath Removal �
- Sheath Radial .
- Sheath Retraction .
- Protector Fitting .
- Collar removal .
- Sheath Puncture �
- Adhesive Hold .
- Needle Penetration �
- Manual Sheath Activation
- -Finger Activation
- Thumb Activation -
- Surface Activation .
- Measurement Testing .
- Manual Sheath Activation by analytical balance .
- . Simulated Use Study
This study was performed to confirm that the safety feature of the proposed device can be safely activated by following the Instructions For Use of the device. The study was conducted in a simulated clinical environment and the safety feature activation was performed by healthcare workers with varied amounts of experience. It was concluded that the proposed Terumo SurGuard 3 Safety Hypodermic Needle met its intended use, and the Instructions for Use were adequate for safe and effective activation of the safety feature.
Results of the verification testing performed on both the predicate device and the proposed device met the acceptance criteria of the functional performance tests of both devices.
20
7
Shelf Life Testing
Shelf life tests both on the predicate device (K113422) and the proposed Terumo SurGuard 3 Safety Hypodermic Needle and with attached syringe (1cc/ml) were performed using accelerated aged samples to simulate a 5-year (60 months) shelf life for this 510(k) submission. The accelerated aging condition was performed in accordance with ASTM F-1980.
- Sheath Activation .
- Sheath Deactivation .
- Sheath Removal .
- . Sheath Radial
- . Sheath Retraction
- Protector Fitting .
- . Collar removal
- Sheath Puncture .
- Adhesive Hold .
- Needle Penetration .
- Manual Sheath Activation
- Finger Activation -
- Thumb Activation
- Surface Activation -
- . Package Seal Strength
Results of verification testing indicated that the functional performance of the proposed Terumo SurGuard®3 Safety Hypodermic Needle and with attached syringe (1cc/ml) is acceptable throughout a 5-year (60months) shelf life. The shelf-life will be confirmed with real time testing.
Biocompatibility Testing
Biocompatibility was established for the Terumo SurGuard®3 Safety Hypodermic Needle manufactured by Terumo (Philippines) Corporation (K113422) which is comprised of blood contacting materials identical to the Terumo SurGuard®3 Safety Hypodermic Needle (26G, 27G and 30G) and with attached syringe (1cc/ml) device. No changes have been made since 510(k) clearance that would require re-testing; therefore, biocompatibility established under K113422 is still applicable.
8
The Terumo SurGuard®3 Safety Hypodermic Needle is classified as Externally Communicating Device, Circulating Blood, Limited Duration of Contact (≤24hr.). The device's blood contacting materials were tested in accordance with the tests recommended in the FDA General Program Memorandum #G95-1 (5/1/95): Use of International Standard ISO - 10993, "Biological Evaluation of Medical Devices part 1: Evaluation and Testing". Results of the testing demonstrate that the blood contacting materials are biocompatible.
None of the data raises any new issues of safety and effectiveness.
Product Risk Analysis
Additionally a product risk analysis was conducted and there were no new issues of safety and effectiveness.
Conclusion: The performance of the TERUMO SurGuard®3 Safety Needle submitted in this 510(k) is substantially equivalent in intended use, design, technology/principles of operation, materials and performance to the legally marketed predicate devices. The proposed devices perform as well as the predicate devices.
F. COMPARISON TO STANDARDS
The Terumo SurGuard®3 Safety Hypodermic Needle complies with the requirements specified in the following standards:
- ISO 23908:2011 Sharps Injury Protection, requirements and test methods . - sharps protection features for single hypodermic needles, introducers for catheters, and needles used for blood sampling
- ISO 7886-1:1993 Sterile Hypodermic Syringes for Single Use .
- ISO 594-1:1986 Conical Fittings with a 6% taper on syringes, needles, . and certain other medical equipment
- ISO 6009:1992/Cor:1:2008 Hypodermic Needles for Single Use color . coding for identification
The Terumo SurGuard 3 Safety Hypodermic Needle also complies with the requirements specified in ISO 7864:1993 - Sterile Hypodermic Needles for Single
9
K122249
page 10 of 10
Use, with the exception of:
Section 13.2a Patency of Lumen: no specifications are given for 26G, 27G and 30G having an ultra thin wall cannula. As a result, these needles cannot be compared to this requirement.
G. ADDITIONAL SAFETY INFORMATION
Manufacturing controls include visual, functional and sterility tests.
The sterility of the device is assured using a sterilization method validated in accordance with ANSI/AAMI/ISO 11137 - Medical Devices - Validation and Routine Control of Radiation Sterilization. The Terumo SurGuard®3 Safety Hypodermic Needle is sterilized to provide a Sterility Assurance Level (SAL) of 10-6.
A specific sterilization dose to provide Sterility Assurance Level (SAL) of 100 is set using bioburden information obtained.
H. CONCLUSION
The performance of the TERUMO® SurGuard®3 Safety Needle submitted in this 510(k) is substantially equivalent in intended use, design, technology/principles of operation, materials and performance to the legally marketed predicate device which is:
-
- K113422 TERUMO® SurGuard®3 Safety Hypodermic Needle with or without syringe manufactured by Terumo (Philippines) Corporation.
Differences among the devices do not raise any significant issues of safety or effectiveness.
- K113422 TERUMO® SurGuard®3 Safety Hypodermic Needle with or without syringe manufactured by Terumo (Philippines) Corporation.
Terumo's statement of substantial equivalence is done solely to comply with the requirements of the Federal Food, Drug and Cosmetic Act and is not intended whatsoever to be the basis for a patent infringement action.
10
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/10/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines representing its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring. MD 20993-0002
Terumo (Philippines) Corporation C/O Mr. Phillip Michael Lester Regulatory Affairs Specialist Terumo Medical Corporation 950 Elkton Boulevard Elkton, Maryland 21921
AUG 28 2012
Re: K122249
Trade/Device Names: TERUMO® SurGuard®3 Safety Needle, 23G, 25G, 26G, 27G and 30G; TERUMO® SurGuard® 3 Hypodermic Syringe with Safety Needle, Icc/mL Regulation Number: 21 CFR 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: II Product Code: FMI, MEG Dated: July 25, 2012 Received: July 30, 2012
Dear Mr. Lester:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
11
Page 2- Mr. Lester
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
For. S. Smith D.
Anthony B. Watson, BS, MS, MBA Director Division of Anesthesiology, General Hospital, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
12
22249
Indications for Use
510(k) Number (if known):
Device Name: TERUMO® SurGuard®3 Safety Needle, 23G, 25G, 26G, 27G and 30G TERUMO® SurGuard®3 Hypodermic Syringe with Safety Needle, 1cc/mL
Indications for Use:
The TERUMO® SurGuard®3 Safety Needle device is intended for use in the aspiration and injection of fluids for medical purposes. The TERUMO SurGuard®3 Safety Needle is compatible for use with standard luer slip and luer lock syringes.
Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needlestick.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Alid Chapman 8/27/12
(Division Sign-Off) (Division of Anesthesiology, General Hospital nfection Control, Dental Devices
510(k) Number: K122249
Page 1 of 1
4